Abstract:Abstract Parathyroid carcinoma (PC) is rare, poses challenges in definitive diagnosis and treatment, and carries a high rate of recurrence and mortality. Atypical parathyroid tumors (APT) have histopathologic features of malignancy but lack unequivocal evidence of invasion and are of uncertain malignant potential. Analysis of genetic alterations that may play a role in PC development, particularly those that might serve as markers of malignant potential, is important for further understanding this disease. FLCN is a gene found on chromosome 17 that encodes folliculin, a ubiquitously expressed protein with roles in multiple cellular processes such as apoptosis and cell signaling. Inactivating FLCN mutations cause Birt-Hogg-Dubé syndrome (BHD), an autosomal dominant condition characterized by benign fibrofolliculomas, pulmonary cysts and spontaneous pneumothorax, and increased risk of renal cancer. Benign parathyroid tumors had previously been reported in a few BHD patients and recently one study has reported a link between FLCN mutations and parathyroid carcinoma. Germline frameshift mutations in FLCN, accompanied by somatic loss of the normal allele, were reported in two unrelated PC patients, both with clinical features suggestive of BHD, but no established diagnosis of BHD. An identical somatic frameshift FLCN mutation was reported in one PC and one APT. Interestingly, the authors noted low coverage of FLCN on whole exome sequencing, resulting in the failure to detect variants identified by Sanger sequencing, thus raising the possibility that prior studies may have missed FLCN variants. To better understand the frequency of germline or somatic FLCN mutations in PC and APT, we performed Sanger sequence analysis of the entire coding region of the FLCN gene on available tumor DNA from 11 PCs and 15 APTs. We identified no inactivating FLCN mutations in any of the PC or APT samples examined. A germline missense variant, resulting in a p.Gly325Val change, predicted to be benign/tolerated by in silico analyses, was seen in one PC and a synonymous variant (c.1233G>A) was seen in one APT. The absence of pathogenic mutations in our series parathyroid carcinoma and atypical parathyroid tumors suggests that FLCN mutations are rare in these parathyroid tumors. Nevertheless, germline FLCN testing and/or additional screening for BHD-related lesions in parathyroid carcinoma patients merits further consideration and study. Citation Format: Callie Burke, Justin Bellizzi, Jessica Costa-Guda, Andrew Arnold. FLCN variants and their role in parathyroid cancer and atypical parathyroid tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 6265.

Genetic screening of the FLCN gene identify six novel variants and a Danish founder mutation

Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation

Detection of Folliculin Gene Mutations in Two Chinese Families with Birt-Hogg-Dube Syndrome.

Novel Germline Mutations in FLCN Gene Identified in Two Chinese Patients with Birt–Hogg–Dubé Syndrome

Bilateral Periventricular Nodular Heterotopia Caused By A Novel Splicing Mutation In The Flna Gene In A Chinese Family

Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer

Guiding the future of clinical care and clinical research in Birt-Hogg-Dubé

Clinical relevance of FLCN mutations in Asian patients with Birt-Hogg-Dube syndrome

Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.

A Novel FLCN Intragenic Deletion Identified by NGS in a BHDS Family and Literature Review

Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report

Birt-Hogg-Dubé Renal Tumors Are Genetically Distinct from Other Renal Neoplasias and Are Associated with Up-Regulation of Mitochondrial Gene Expression

Progress in diagnosis and treatment of Birt-Hogg-Dubé syndrome

A retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions

A splicing mutation of the FLCN gene is associated with Birt-Hogg-Dubé syndrome characterized by familial and recurrent spontaneous pneumothorax: A case report

Birt-Hogg-Dubé Syndrome in Two Chinese Families with Mutations in the FLCN Gene

A Novel Single Nucleotide Splice Site Mutation in FHL1 Confirms an Emery-Dreifuss Plus Phenotype with Pulmonary Artery Hypoplasia and Facial Dysmorphology.

The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants

Abstract 6265: FLCN variants and their role in parathyroid cancer and atypical parathyroid tumors

Birt-Hogg Dube Syndrome: Prevalence and Clinical Characteristics Determined from a National Referral Centre

New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome